LumaCyte

LumaCyte is a privately held bioanalytics company providing innovative, label-free single-cell analysis technology to the advanced therapeutics manufacturing sector. Its proprietary Laser Force Cytology™ (LFC) and Radiance® platform enable real-time, non-destructive measurement of intrinsic cellular properties, offering a significant advantage over traditional, label-dependent assays like flow cytometry. The company targets critical pain points in the development and manufacturing of cell and gene therapies, biologics, and vaccines by delivering predictive insights for process optimization, quality attribute monitoring, and regulatory support. Founded in 2014 and based in Charlottesville, Virginia, LumaCyte is positioned as a tools and instrumentation provider within the high-growth advanced therapy and biomanufacturing markets.

Laser Force Cytology™ (LFC) - A label-free, optical technology that measures intrinsic biophysical and biochemical properties of single cells by quantifying the optical forces exerted on them as they flow through a laser beam, enabling real-time phenotypic analysis without labels.

Competes against traditional flow cytometry (Beckman Coulter, BD Biosciences) and label-free alternatives like imaging flow cytometry (Luminex/Amnis), impedance-based analyzers (NanoEntek, OMNI Life Science), and other optical/ biophysical analysis tools. Differentiation hinges on the unique Laser Force Cytology™ mechanism and real-time, non-destructive analysis.